Loading clinical trials...

Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT01532336

Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis

The purpose of this study is to evaluate the clinical and microbiological efficacy and safety of NVC-422 compared to vehicle for adenoviral conjunctivitis. Adults and children one year of age and olde...

Lead sponsor: NovaBay Pharmaceuticals, Inc.•24 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETEDPhase 2

Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis

NCT03749317 · Adenoviral Conjunctivitis

TERMINATEDPhase 2

FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis

NCT00941486 · Acute Adenoviral Conjunctivitis

TERMINATEDPhase 3

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo

NCT02998541 · Adenoviral Conjunctivitis

COMPLETEDNA

Reducing Adenoviral Patient Infected Days

NCT02472223 · Conjunctivitis, Adenoviral Conjunctivitis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 28, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment500

Start dateMay 2012

Last updatedMay 28, 2015

Condition

Adenoviral Conjunctivitis

Locations shown

Glendale, California

Los Angeles, California

Petaluma, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 28, 2015Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions